Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. Aliment Pharmacol Ther. 2018 01; 47(2):219-228.